Dr. Neil Kumar, MD
Nephrology (Kidney) (Nephrology Physician)
2410 Nw Edenbower Blvd Ste 176
Roseburg, OR 97471
Who else practices at this address →
Douglas County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 44
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 720
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
- Nephrology Physician primary
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mercy Medical Center Roseburg, OR
- Bay Area Hospital Coos Bay, OR
- Curry General Hospital Gold Beach, OR
- Southern Coos Hospital & Health Center Bandon, OR
- Lower Umpqua Hospital District Reedsport, OR
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 720
- Services billed
- 39,809
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 22,940 | 105 |
| Injection, denosumab, 1 mg | 11,340 | 107 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,862 | 650 |
| Injection of drug or substance under skin or into muscle | 789 | 196 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 492 | 81 |
| Blood count, hemoglobin | 371 | 163 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 311 | 42 |
| Dialysis services, per day, less than full month service (20 years or older) | 306 | 21 |
| Urinalysis, manual test | 166 | 135 |
| Complete ultrasound scan behind abdominal cavity | 122 | 122 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Potassium Chloride Other prescribers in Roseburg, OR | 1,033 |
| Furosemide Other prescribers in Roseburg, OR | 844 |
| Calcitriol Other prescribers in Roseburg, OR | 603 |
| Bumetanide Other prescribers in Roseburg, OR | 591 |
| Losartan Potassium Other prescribers in Roseburg, OR | 555 |
| Clonidine Hcl Other prescribers in Roseburg, OR | 389 |
| Gabapentin Other prescribers in Roseburg, OR | 306 |
| Pantoprazole Sodium Other prescribers in Roseburg, OR | 234 |
| Tamsulosin Hcl Other prescribers in Roseburg, OR | 226 |
| Prosol (parenteral amino acid 20% no.1) | 222 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 23 companies reported 93 payments worth $20,172 in total to this clinician.
| Travere Therapeutics, Inc. | $5,197 |
|---|---|
| Ardelyx, Inc. | $5,193 |
| Sobi, Inc | $4,855 |
| Amgen Inc. | $3,466 |
| Novartis Pharmaceuticals Corporation | $310 |
| Madrigal Pharmaceuticals | $217 |
| Novo Nordisk Inc | $207 |
| Akebia Therapeutics Inc | $133 |
| Consulting Fee | $7,340 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $6,465 |
| Travel and Lodging | $4,064 |
| Food and Beverage | $2,173 |
| Education | $129 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sobi, Inc Dec 4, 2025 | Consulting Fee | $3,740 |
| Travere Therapeutics, Inc. Nov 18, 2025 | Consulting Fee | $3,600 |
| Ardelyx, Inc. Oct 18, 2025 | Compensation for services other than consulting (speaking, faculty) XPHOZAH 30 MG · NEPHROLOGY | $3,040 |
| Amgen Inc. Feb 3, 2025 | Compensation for services other than consulting (speaking, faculty) KRYSTEXXA · Inflammation/Rare Disease | $2,400 |
| Ardelyx, Inc. Oct 18, 2025 | Travel and Lodging XPHOZAH 30 MG · NEPHROLOGY · travel to CHICAGO, IL · in-kind | $852 |
| Ardelyx, Inc. Oct 18, 2025 | Travel and Lodging XPHOZAH 30 MG · NEPHROLOGY · travel to CHICAGO, IL · in-kind | $717 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Denver, CO · in-kind | $565 |
| Sobi, Inc Dec 4, 2025 | Travel and Lodging travel to Bellevue, WA | $538 |
| Ardelyx, Inc. Oct 18, 2025 | Travel and Lodging XPHOZAH 30 MG · NEPHROLOGY · travel to CHICAGO, IL | $429 |
| Amgen Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) KRYSTEXXA · Inflammation/Rare Disease | $400 |
All 19 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Sobi, Inc Dec 4, 2025 | Consulting Fee | $3,740 |
| Sobi, Inc Dec 4, 2025 | Travel and Lodging travel to Bellevue, WA | $538 |
| Sobi, Inc Dec 4, 2025 | Travel and Lodging travel to Bellevue, WA | $396 |
| Travere Therapeutics, Inc. Nov 18, 2025 | Consulting Fee | $3,600 |
| Travere Therapeutics, Inc. Nov 18, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $281 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Denver, CO · in-kind | $565 |
| Amgen Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) KRYSTEXXA · Inflammation/Rare Disease | $400 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Denver, CO · in-kind | $287 |
| Ardelyx, Inc. Oct 18, 2025 | Compensation for services other than consulting (speaking, faculty) XPHOZAH 30 MG · NEPHROLOGY | $3,040 |
| Ardelyx, Inc. Oct 18, 2025 | Travel and Lodging XPHOZAH 30 MG · NEPHROLOGY · travel to CHICAGO, IL · in-kind | $852 |
| Ardelyx, Inc. Oct 18, 2025 | Travel and Lodging XPHOZAH 30 MG · NEPHROLOGY · travel to CHICAGO, IL · in-kind | $717 |
| Ardelyx, Inc. Oct 18, 2025 | Travel and Lodging XPHOZAH 30 MG · NEPHROLOGY · travel to CHICAGO, IL | $429 |
| Novo Nordisk Inc Jul 10, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novo Nordisk Inc Jul 10, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Amgen Inc. Jun 16, 2025 | Compensation for services other than consulting (speaking, faculty) KRYSTEXXA · Inflammation/Rare Disease | $400 |
| Novo Nordisk Inc Mar 10, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novo Nordisk Inc Mar 10, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novartis Pharmaceuticals Corporation Feb 14, 2025 | Compensation for services other than consulting (speaking, faculty) Fabhalta · Immunology | $225 |
| Amgen Inc. Feb 3, 2025 | Compensation for services other than consulting (speaking, faculty) KRYSTEXXA · Inflammation/Rare Disease | $2,400 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.